Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis

By sjmartinez • November 11, 2023

Curtis JR, Strand V, Golombek SJ, Karpouzas GA, Zhang L, Wong A, Patel K, Dines J, Akmaev VR. Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis. Rheumatol Ther. 2023 Nov 10. doi: 10.1007/s40744-023-00618-1. Epub ahead of print. PMID: 37948030.

Tags: Harbor UCLA, Molecular signature, Precision medicine, Publications, Response classifier, Rheumatoid arthritis, Rheumatology, Treatment selection

Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade[...]

Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation

Rhee CM, Zisman-Ilani Y, Kalantar-Zadeh K, Nguyen DV. Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation. Curr Opin[...]

Sex hormones and sexual health in chronic kidney disease before and after kidney transplantation

Lobo AS, Vaughan L, Ainsworth AJ, Felt M, Elali I, Arriola-Montenegro J, Garovic VD, Kattah AG. Sex hormones and sexual health in chronic kidney disease[...]